Skip to content
Nutrition & metabolismCohort study3 min read

8 weeks of very-low-calorie keto diet: fatty liver and fat mass improved in 55 adults

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Short-Term Changes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Related Circulating Biomarkers Following a Very-Low Calorie Ketogenic Diet (VLCKD): A Paired Longitudinal Analysis. · Nutrients · 2026 · Original paper ↗

Key takeaway

In 55 adults with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), 8 weeks of a very-low-calorie ketogenic diet (VLCKD) was followed by improved liver steatosis (CAP p < 0.0001), liver stiffness (p = 0.0005), waist and fat mass. There was no control group, so the changes cannot be separated from weight loss itself or from the passage of time.

Study design

Cohort study

Reading basis

Published abstract

Reading focus

Association & confounding

The research question

Fatty liver disease is the most common chronic liver disease worldwide and is rising with obesity. The Mediterranean diet is the usual dietary advice but is hard to follow for some people. The authors assessed what an 8-week very-low-calorie ketogenic diet does to liver and metabolic markers in adults with obesity and MASLD.

Who and how

Uncontrolled pre-post study of 55 adults aged 18-64 years with obesity recruited at the Center of Nutrition for Obesity and Metabolic Diseases, National Institute of Gastroenterology "Saverio de Bellis" Research Hospital in Castellana Grotte, Bari, Italy. Anthropometry, body composition by bioelectrical impedance (BIA), liver status by FibroScan, serum biochemistry and circulating biomarkers of adipose tissue dysfunction were measured at baseline (T0) and after the 8-week VLCKD (T1). The abstract does not detail the diet's composition or the statistical tests.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Liver fat improved: the FibroScan steatosis measure (CAP) changed significantly (p < 0.0001).
  2. 2
    Liver stiffness also improved significantly (p = 0.0005).
  3. 3
    Waist circumference (p < 0.0001) and fat mass (p < 0.0001) improved significantly.
  4. 4
    Leptin fell significantly and sex hormone-binding globulin (SHBG) rose significantly (p < 0.0001). The abstract gives no effect sizes or confidence intervals.

Limits & uncertainty

  1. 1
    No control group: improvements may come from weight loss or calorie restriction in general, not from ketosis, and cannot be compared with the Mediterranean diet.
  2. 2
    Only 8 weeks of follow-up, so it says nothing about whether benefits last or what happens when the diet ends.
  3. 3
    The abstract reports p values only, with no effect sizes, and does not describe dropouts or adverse effects.
  4. 4
    Participants were treated at one hospital centre, and this reading is based on the abstract only.

What to take from it

Over 8 weeks, a medically supervised very-low-calorie ketogenic diet was associated with better liver measures and less body fat in this group. It does not show the diet beats other approaches or that results last. Very-low-calorie diets are not for everyone and should be undertaken with clinical supervision.

Reading your own data

If you follow a calorie-restricted plan, weekly average weight and waist measurements on the same scale and tape under the same conditions are more informative than daily changes. Liver fat and stiffness (FibroScan) and blood markers need a clinic, and cannot be estimated from a wearable.

How to read this evidence

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide. Its prevalence is constantly increasing, particularly among obese individuals. Lifestyle modifications remain the first-line intervention for the management and treatment of MASLD. The most widely recommended dietary regime for MASLD is the Mediterranean Diet (MedDiet). Despite its countless benefits, this dietary regimen is difficult to follow in some cases. This study aimed to assess the effects of an 8-week Very Low-Calorie Ketogenic Diet (VLCKD) in obese patients with MASLD.

Methods

The study included 55 obese adults aged 18-64 years, recruited from the Center of Nutrition for Obesity and Metabolic Diseases, National Institute of Gastroenterology "Saverio de Bellis" Research Hospital (Castellana Grotte, Bari, Italy). Anthropometry, body composition (BIA), liver status (FibroScan^(®)), serum biochemistry and circulating biomarkers of adipose dysfunction were assessed at baseline (T0) and post-intervention (T1).

Results

Significant improvements in liver steatosis (CAP p < 0.0001), liver stiffness ( p = 0.0005), anthropometric parameters (waist p < 0.0001), and body composition (FM p <0.0001) were observed. A significant reduction in leptin levels and an increase in sex hormone-binding globulin (SHBG p < 0.0001) were also observed.

Conclusions

In this uncontrolled pre-post analysis, the 8-week VLCKD intervention was associated with improvements in hepatic steatosis, body weight, and fat mass, and selected circulating biomarkers of adipose tissue dysfunction in adults with obesity and MASLD.

Sources & attribution

Short-Term Changes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Related Circulating Biomarkers Following a Very-Low Calorie Ketogenic Diet (VLCKD): A Paired Longitudinal Analysis.

Tatoli R, Donghia R, Pesole PL, Di Chito M, Stabile D, Ferro A, Ancona A, Casimo G, Giannelli G.

Nutrients · 2026-10-16

DOI: 10.3390/nu18203397 ↗PubMed · 42942968 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Trial meta-analysis

Early time-restricted eating linked to more weight loss and lower insulin than late eating

Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.

BMJ Medicine

In-depth explainersRead study →
·Randomised trial

An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss

Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.

The New England Journal of Medicine

In-depth explainersRead study →
·Randomised trial

In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain

In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.

Cell Metabolism

In-depth explainersRead study →
·Randomised trial

Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)

Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.

The New England Journal of Medicine

In-depth explainersRead study →
Nutrition & metabolism →